TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 SEK)
Closing information | 2024/06 | 2023/06 | 2021/12 |
Turnover |
330,221
|
434,633
|
243,890 |
Financial expenses |
931
|
1,411
|
738 |
Earnings before taxes |
26,219
|
7,848
|
7,164 |
EBITDA |
26,222
|
9,518
|
8,094 |
Total assets |
378,079
|
248,809
|
264,550 |
Current assets |
377,989
|
248,536
|
263,992 |
Current liabilities |
195,867
|
87,134
|
108,582 |
Equity capital |
67,212
|
46,675
|
40,968 |
- share capital |
200
![]() |
200
![]() |
200 |
Employees (average) |
38
|
46
|
40 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2021/12 |
Solvency |
17.8%
|
18.8%
|
15.5% |
Turnover per employee |
8,690
|
9,449
|
6,097 |
Profit as a percentage of turnover |
7.9%
|
1.8%
|
2.9% |
Return on assets (ROA) |
7.2%
|
3.7%
|
3.0% |
Current ratio |
193.0%
|
285.2%
|
243.1% |
Return on equity (ROE) |
39.0%
|
16.8%
|
17.5% |
Change turnover |
-104,412
|
190,743
|
18,043 |
Change turnover % |
-24%
|
78%
|
8% |
Chg. No. of employees |
-8
|
6
|
2 |
Chg. No. of employees % |
-17%
|
15%
|
5% |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.